Key Financial Data Of Reporting Company

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7362167

Concept 2023-09-01 to
2023-11-30
As at
2023-11-30
2023-03-01 to
2023-11-30
As at
2023-02-28
2022-03-01 to
2023-02-28
2022-09-01 to
2022-11-30
2022-03-01 to
2022-11-30
As at
2022-11-30
Key financial data of reporting company
Business results of reporting company
Net sales
102,827,000,000 JPY
128,330,000,000 JPY
91,881,000,000 JPY
Ordinary profit (loss)
16,661,000,000 JPY
16,051,000,000 JPY
13,003,000,000 JPY
Net assets
271,496,000,000 JPY
258,408,000,000 JPY
271,829,000,000 JPY
Total assets
334,909,000,000 JPY
313,917,000,000 JPY
336,880,000,000 JPY
Basic earnings (loss) per share
48.25
156.64
148.01
37.88
119.46
Diluted earnings per share
156.48
147.88
119.36
Equity-to-asset ratio
0.803 xbrli:pure
0.816 xbrli:pure
0.800 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.